Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study

CSF biomarkers, including total-tau, neurofilament light chain (NfL) and amyloid-β, are increasingly being used to define and stage Alzheimer's disease. These biomarkers can be measured more quickly and less invasively in plasma and may provide important information for early diagnosis of Alzhe...

Celý popis

Podrobná bibliografia

Vydané v:	Brain (London, England : 1878) Ročník 143; číslo 4; s. 1220
Hlavní autori:	de Wolf, Frank, Ghanbari, Mohsen, Licher, Silvan, McRae-McKee, Kevin, Gras, Luuk, Weverling, Gerrit Jan, Wermeling, Paulien, Sedaghat, Sanaz, Ikram, M Kamran, Waziry, Reem, Koudstaal, Wouter, Klap, Jaco, Kostense, Stefan, Hofman, Albert, Anderson, Roy, Goudsmit, Jaap, Ikram, M Arfan
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England 01.04.2020
Predmet:	dementia plasma biomarkers Alzheimer’s disease Aβ42 NfL
ISSN:	1460-2156, 1460-2156
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!